Design Therapeutics, Inc.
DSGN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $23 | $21 | $27 | $299 |
| Short-Term Investments | $223 | $261 | $304 | $85 |
| Receivables | $1 | $1 | $1 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $1 | $4 | $1 |
| Total Curr. Assets | $248 | $285 | $335 | $385 |
| Property Plant & Equip (Net) | $4 | $5 | $6 | $5 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $4 | $5 | $6 | $5 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $252 | $290 | $341 | $391 |
| Liabilities | – | – | – | – |
| Payables | $2 | $2 | $3 | $2 |
| Short-Term Debt | $1 | $1 | $1 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $5 | $7 | $7 | $3 |
| Total Curr. Liab. | $8 | $10 | $11 | $5 |
| LT Debt | $2 | $2 | $3 | $3 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $2 | $2 | $3 | $3 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2 | $3 | $4 | $4 |
| Total Liabilities | $10 | $12 | $14 | $8 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$227 | -$178 | -$111 | -$47 |
| AOCI | $0 | $0 | -$3 | -$0 |
| Other Equity | $469 | $455 | $441 | $430 |
| Total Equity | $242 | $278 | $327 | $382 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $252 | $290 | $341 | $391 |
| Net Debt | -$20 | -$18 | -$23 | -$295 |